** Shares in Ambu AMBUb.CO rise 9.5% after the Danish medical equipment maker posted on Tuesday new long term financial targets and kept its full year outlook, EBIT margin guide unchanged
** Ambu now expects its organic revenue to grow 11-13% CAGR by 2029/30 against +10% for FY 2027/28 seen earlier, while it expects its EBIT margins to reach +20% by FY 2029/30
** While the new targets are largely in line with analysts expectations, J.P.Morgan says it expects a relief rally
** The company kept its EBIT margin guide for FY27/28 unchanged, while there had been a concern over a potential downgrade, JPM says
** Ambu shares rise to the top of STOXX 600 .STOXX
(Reporting by Boleslaw Lasocki)
((boleslaw.lasocki@thomsonreuters.com; +48 58 769 66 00;))